Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT02399124

Post Marketing Surveillance for PROSENSE™ a Cryotherapy Treatment of Renal Cell Carcinoma

ICE-SECRET PROSENSE™ Cryotherapy For Renal Cell Carcinoma Trial

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
120 (estimated)
Sponsor
IceCure Medical Ltd. · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This experiment is designed for post marketing data collection of a cryosurgical system \[PROSENSE™ of IceCure Medical\], for the treatment of renal cell carcinoma (RCC).

Detailed description

A post marketing data collection of a cryosurgical system \[PROSENSE™\] of IceCure Medical\], for the treatment of renal cell carcinoma (RCC).

Conditions

Interventions

TypeNameDescription
DEVICEPROSENSE™single arm, open label, PROSENSE™ treatment

Timeline

Start date
2014-07-01
Primary completion
2026-02-01
Completion
2026-03-01
First posted
2015-03-26
Last updated
2026-01-06

Locations

2 sites across 1 country: Israel

Source: ClinicalTrials.gov record NCT02399124. Inclusion in this directory is not an endorsement.